|
Recent Publications
- Wang HB, Zhang H, Zhang JP, Li Y, Zhao B, Feng GK, Du Y, Xiong D, Zhong Q, Liu
WL, Du H, Li MZ, Huang WL, Tsao SW, Hutt-Fletcher L, Zeng YX, Kieff E, Zeng MS.
Neuropilin 1 is an entry factor that promotes EBV infection of nasopharyngeal
epithelial cells. Nat Commun. 2015 Feb 11;6:6240.
- Zhou H, Schmidt SC, Jiang S, Willox B, Bernhardt K, Liang J, Johannsen EC,
Kharchenko P, Gewurz BE, Kieff E, Zhao B. Epstein-Barr Virus Oncoprotein
Super-enhancers Control B Cell Growth. Cell Host Microbe. 2015 Feb
11;17(2):205-16.
- Schmidt SC, Jiang S, Zhou H, Willox B, Holthaus AM, Kharchenko PV, Johannsen
EC, Kieff E, Zhao B. Epstein-Barr virus nuclear antigen 3A partially coincides
with EBNA3C genome-wide and is tethered to DNA through BATF complexes. Proc Natl
Acad Sci U S A. 2015 Jan 13;112(2):554-9.
- Zhao B, Barrera LA, Ersing I, Willox B, Schmidt SC, Greenfeld H, Zhou H, Mollo
SB, Shi TT, Takasaki K, Jiang S, Cahir-McFarland E, Kellis M, Bulyk ML, Kieff E,
Gewurz BE. The NF-κB genomic landscape in lymphoblastoid B cells. Cell Rep. 2014
Sep 11;8(5):1595-606.
- Jiang S, Willox B, Zhou H, Holthaus AM, Wang A, Shi TT, Maruo S, Kharchenko
PV, Johannsen EC, Kieff E, Zhao B. Epstein-Barr virus nuclear antigen 3C binds to
BATF/IRF4 or SPI1/IRF4 composite sites and recruits Sin3A to repress CDKN2A. Proc
Natl Acad Sci U S A. 2014 Jan 7;111(1):421-6.
- Portal D, Zhou H, Zhao B, Kharchenko PV, Lowry E, Wong L, Quackenbush J,
Holloway D, Jiang S, Lu Y, Kieff E. Epstein-Barr virus nuclear antigen leader
protein localizes to promoters and enhancers with cell transcription factors and
EBNA2. Proc Natl Acad Sci U S A. 2013 Nov 12;110(46):18537-42.
- Zhou X, Gewurz BE, Ritchie JM, Takasaki K, Greenfeld H, Kieff E, Davis BM,
Waldor MK. A Vibrio parahaemolyticus T3SS effector mediates pathogenesis by
independently enabling intestinal colonization and inhibiting TAK1 activation.
Cell Rep. 2013 May 30;3(5):1690-702.
- Liu CD, Chen YL, Min YL, Zhao B, Cheng CP, Kang MS, Chiu SJ, Kieff E, Peng
CW. The nuclear chaperone nucleophosmin escorts an Epstein-Barr Virus nuclear
antigen to establish transcriptional cascades for latent infection in human B
cells. PLoS Pathog. 2012;8(12):e1003084.
- Yasui T, Sakakibara-Yada K, Nishimura T, Morita K, Tada S, Mosialos G, Kieff
E, Kikutani H. Protein kinase N1, a cell inhibitor of Akt kinase, has a central
role in quality control of germinal center formation. Proc Natl Acad Sci U S A.
2012 Dec 18;109(51):21022-7.
- Rozenblatt-Rosen O, Deo RC, Padi M, Adelmant G, Calderwood MA, Rolland T,
Grace M, Dricot A, Askenazi M, Tavares M, Pevzner SJ, Abderazzaq F, Byrdsong D,
Carvunis AR, Chen AA, Cheng J, Correll M, Duarte M, Fan C, Feltkamp MC, Ficarro
SB, Franchi R, Garg BK, Gulbahce N, Hao T, Holthaus AM, James R, Korkhin A,
Litovchick L, Mar JC, Pak TR, Rabello S, Rubio R, Shen Y, Singh S, Spangle JM,
Tasan M, Wanamaker S, Webber JT, Roecklein-Canfield J, Johannsen E, Barabási AL,
Beroukhim R, Kieff E, Cusick ME, Hill DE, Münger K, Marto JA, Quackenbush J, Roth
FP, DeCaprio JA, Vidal M. Interpreting cancer genomes using systematic host
network perturbations by tumour virus proteins. Nature. 2012 Jul
26;487(7408):491-5.
- Gulbahce N, Yan H, Dricot A, Padi M, Byrdsong D, Franchi R, Lee DS,
Rozenblatt-Rosen O, Mar JC, Calderwood MA, Baldwin A, Zhao B, Santhanam B, Braun
P, Simonis N, Huh KW, Hellner K, Grace M, Chen A, Rubio R, Marto JA, Christakis
NA, Kieff E, Roth FP, Roecklein-Canfield J, Decaprio JA, Cusick ME, Quackenbush
J, Hill DE, Münger K, Vidal M, Barabási AL. Viral perturbations of host networks
reflect disease etiology. PLoS Comput Biol. 2012;8(6):e1002531.
- Gewurz BE, Towfic F, Mar JC, Shinners NP, Takasaki K, Zhao B, Cahir-McFarland
ED, Quackenbush J, Xavier RJ, Kieff E. Genome-wide siRNA screen for mediators of
NF-κB activation. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2467-72.
- Zhao B, Zou J, Wang H, Johannsen E, Peng CW, Quackenbush J, Mar JC, Morton
CC, Freedman ML, Blacklow SC, Aster JC, Bernstein BE, Kieff E. Epstein-Barr virus
exploits intrinsic B-lymphocyte transcription programs to achieve immortal cell
growth. Proc Natl Acad Sci U S A. 2011 Sep 6;108(36):14902-7.
- Wang H, Zou J, Zhao B, Johannsen E, Ashworth T, Wong H, Pear WS, Schug J,
Blacklow SC, Arnett KL, Bernstein BE, Kieff E, Aster JC. Genome-wide analysis
reveals conserved and divergent features of Notch1/RBPJ binding in human and
murine T-lymphoblastic leukemia cells. Proc Natl Acad Sci U S A. 2011 Sep
6;108(36):14908-13.
- Xing L, Kieff E. cis-Acting effects on RNA processing and Drosha cleavage
prevent Epstein-Barr virus latency III BHRF1 expression. J Virol. 2011
Sep;85(17):8929-39.
- Gewurz BE, Mar JC, Padi M, Zhao B, Shinners NP, Takasaki K, Bedoya E, Zou JY,
Cahir-McFarland E, Quackenbush J, Kieff E. Canonical NF-kappaB activation is
essential for Epstein-Barr virus latent membrane protein 1 TES2/CTAR2 gene
regulation. J Virol. 2011 Jul;85(13):6764-73.
- Verweij FJ, van Eijndhoven MA, Hopmans ES, Vendrig T, Wurdinger T,
Cahir-McFarland E, Kieff E, Geerts D, van der Kant R, Neefjes J, Middeldorp JM,
Pegtel DM. LMP1 association with CD63 in endosomes and secretion via exosomes
limits constitutive NF-κB activation. EMBO J. 2011 Jun 1;30(11):2115-29.
- Portal D, Zhao B, Calderwood MA, Sommermann T, Johannsen E, Kieff E. EBV
nuclear antigen EBNALP dismisses transcription repressors NCoR and RBPJ from
enhancers and EBNA2 increases NCoR-deficient RBPJ DNA binding. Proc Natl Acad Sci
U S A. 2011 May 10;108(19):7808-13.
- Maruo S, Zhao B, Johannsen E, Kieff E, Zou J, Takada K. Epstein-Barr virus
nuclear antigens 3C and 3A maintain lymphoblastoid cell growth by repressing
p16INK4A and p14ARF expression. Proc Natl Acad Sci U S A. 2011 Feb
1;108(5):1919-24.
- Kang MS, Lee EK, Soni V, Lewis TA, Koehler AN, Srinivasan V, Kieff E.
Roscovitine inhibits EBNA1 serine 393 phosphorylation, nuclear localization,
transcription, and episome maintenance. J Virol. 2011 Mar;85(6):2859-68.
|
Refer to the full publication list, here
|